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Abstract: In this work, several benzothiazole-based aminosquaraine dyes, displaying strong
absorption within the so-called phototherapeutic window (650–800 nm), were synthesized. The ability,
of all the new dyes, to generate singlet oxygen was assessed by determining the correspondent
phosphorescence emission and through the comparison with a standard. The quantum yields of
singlet oxygen generation were determined and exhibited to be strongly dependent on the nature of
the amino substituents introduced in the squaric ring. The photodynamic activity of the synthesized
dyes was tested against four human tumor cell lines: breast (MCF-7), lung (NCI-H460), cervical (HeLa)
and hepatocellular (HepG2) carcinomas; and a non-tumor porcine liver primary cell culture (PLP2).
All the compounds synthesized were found to be able to inhibit tumor cells growth upon irradiation
more than in the dark, in most of the cases, very significantly. Considering the photodynamic activity
exhibited and the low toxicity displayed for the non-tumor cells, some of the synthetized dyes can be
regarded as potential candidates as photosensitizers for PDT.
Keywords: squaraine; singlet oxygen; photodynamic therapy
1. Introduction
Photodynamic therapy (PDT) has emerged as a very promising treatment for certain types of
cancer and other non-oncologic disorders [1]. Over the years, PDT has received regulatory approval
worldwide for several conditions and has now become an established therapeutic modality [2].
The basic principle underlying this therapeutic approach is simple: a light-absorbing molecule,
after being administrated to the patient, is activated with light of an appropriate wavelength and
gives rise to the production of reactive oxygen species (ROS). This species are responsible to induce
damage of the surrounding cells [3]. Following interaction with light, the sensitizer, which is firstly
excited to its excited singlet state, may efficiently populate, via intersystem crossing, the longer-lived
excited triplet state. The triplet state of the sensitizer can then produce ROS by two different competing
mechanisms [4]. In a Type I reaction, the sensitizer in the triplet state can react with organic substrates
or solvents to generate free radicals that subsequently interact with oxygen to generate ROS such
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as superoxide radical anion and hydroxyl radical. Alternatively, it can transfer its energy directly to
surrounding ground-state triplet oxygen to produce highly cytotoxic singlet state oxygen in a process
called Type II reaction.
Both Type I and Type II reactions can occur in parallel. Their relative contribution depending
chiefly on the nature of the sensitizer and the concentration of oxygen [5]. However, singlet oxygen,
which acts catalytically, is generally considered to be the main cytotoxic agent responsible for the
photodynamic effect [6]. Independently of the nature of the ROS generated during the photodynamic
process, the ultimate outcome is the cell destruction, which can occur by three main mechanisms:
direct cell death, either by apoptosis, necrosis or autophagy [7], vascular collapse and ensuing tissue
hypoxia [8], and activation of inflammatory and immune responses [9]. Because the photodynamic
process only takes place when the photosensitizer, oxygen and light are present simultaneously, PDT
comes to be a particularly selective modality, with unique advantages compared to conventional tumor
therapies such as surgery, chemotherapy and radiotherapy [10,11].
Photofrin®, a mixture of hematoporphyrin derivatives, was the first photosensitizer to receive
regulatory approval in several countries for the treatment of various cancers. After more than
twenty years is still the most frequently used PDT sensitizer in clinical practice [12]. Despite its
popularity, Photofrin® has several disadvantages, including chemical inhomogeneity, prolonged skin
photosensitivity, low absorption of light and poor tissue penetration of light [13]. These drawbacks
impelled a large research effort towards the development of new molecules that could meet the
main requirements of an ideal sensitizer. Amongst these are [14]: (i) to be a single chemical entity;
(ii) minimal dark toxicity and cytotoxicity only upon illumination; (iii) rapid clearance from the body
to provide low systemic toxicity; (iv) high triplet quantum yield to efficiently generate ROS, namely
single oxygen, upon irradiation; (v) strong absorption in the phototherapeutic window (650–800 nm),
where the depth of light penetration in tissue is maximal, to allow the use of low drug dosages.
While no ideal photosensitizer has yet been discovered, a number of the so-called second
generation photosensitizers have been developed, either porphyrin-based or non-porphyrin
compounds, a small number of which have already granted regulatory approval for clinical
oncotherapy while some of others are currently under clinical trials [12,15–17].
Squaraine dyes, which are the condensation products of squaric acid with electron rich substrates,
are a family of compounds which have found wide application in the domain of photonics due to their
unique properties, namely sharp and intense absorption within the visible to near-infrared range [18].
These same properties also turned them attractive for several biological applications, including as
sensitizers for PDT [19]. As a consequence, structural modification of squaraine dyes become a very
active area of research. Though a considerable number of different squaraine compounds has been
developed envisioning their use as PDT sensitizers, both the in vitro and in vivo evaluation of their
photodynamic capacity has been poorly addressed [20–34].
Aminosquaraines, a particular class of cationic squaraine dyes bearing an amino group replacing
one of the oxygens atoms of the central four member ring, have recently been shown to possess
photodynamic activity against several human tumor cell lines [35,36]. Aminosquaraines are envisioned
to possess some potential advantages over the common zwitterionic counterparts as their cationic
character may facilitate cellular uptake, benefiting from the cell’s membrane potential, while,
at the same time, the amino group may conveniently favor the interaction with the biological
medium. Moreover, besides the electron-donating character of the amino auxchromes red-shifts dye’s
absorption [37,38], the presence of the amino group on the squaric ring may imparts a certain degree
of additional rigidification to the molecule’s structure. This can diminish the non-radiative decay by
photoisomerization leading to an inherent increase of the intersystem crossing efficiency from the
singlet to the triplet state of the sensitizer, and, ultimately, of the efficiency of singlet oxygen generation.
Herein we describe the synthesis of several new symmetrical diiodinated aminosquaraines and
the evaluation of their singlet oxygen generation ability and photocytotoxicity against selected human
tumor cell lines.
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2. Results and Discussion
2.1. Synthesis of Dyes
The molecular design rationale of the aminosquaraines synthesized was driven by the attempt to
amend molecule’s rigidity, which influences the singlet oxygen production ability, dye’s maximum
absorption, which depends on the electron-donating characteristics of the amine auxochrome, and the
ability to establish intermolecular hydrogen bonds, which may increase water solubility and provide a
potential means for interaction with biological substrates. Therefore, the strategy consisted in selecting
substituent groups able to generate secondary and tertiary amines, some of which possessing flexible
hydroxyethyl arms.
Aminosquaraines 5a–e were prepared by an expeditious synthetic method developed earlier by
some of us [37], based on the methylation of one of the oxygen atoms of the squaraine core followed
by nucleophilic substitution of the so-formed methoxy group by appropriate amines (Scheme 1).
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Scheme 1. Synthesis of squaraine dyes 5a–e.
Thus, condensation of two olar equivalents of benzothiazolium salt 2, easily prepared by
N-alkylation of 6-iodo-2-methylbenzothiazole (1) with iodoethane, with one equivalent of squaric
acid in refluxing n-butanol/pyridine, resulted in the starting zwitterionic squaraine 3. Methylation of
the latter with methyl trifluoromethanessulfonate produced the crucial O-methyl ether derivative 4
from which the triflate analogues of 5a–e could be obtained by treatment with the appropriate amines.
Counter-ion exchange by iodine by treatment of the methanolic solutions of the dyes with excess 14%
aqueous KI, produced the final aminosquaraine iodid s 5a–e in rather good yields. The count r ion
exchange by iodine is carried out to potent ally increase singlet oxygen generation through the external
heavy atom effect [39]. As previously observed for several aminosquaraine dyes bearing a secondary
amino group in the squaric ring [37,38], the two methylene protons of the polymethylene chain of 5b
and 5d appear in the 1H-NMR spectrum as separated signals as consequence of the consequent local
magnetic field inhomogeneity, resulting from the intramolecular hydrogen bonding and/or hindered
rotation around the C-N bond linking the amino substituent to the squaric ring.
2.2. Photochemical Characterization
2.2.1. UV-Visible Absorption Spectroscopy
All synthesized aminosquaraines 5a–e display sharp and strong absorption in the red end of the
visible spectrum, within the phototherapeutic window (Figure 1, Table 1). The absorption of dyes
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5a–e is shifted bathochromically in relation to the non-substituted zwitterionic squaraine precursor
3. The observed shifts ranging from 1 to 22 nm. The extent of the bathochromic shifts depends, in a
direct way, on the electron donating ability of the amino auxochrome. This typical donor-acceptor
mechanism is an usual feature of the chromophoric system of this class of compounds [37,38,40].
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Table 1. Visible spectral data and fluoresce ce a si let oxygen generation quantum yields of
squar ine dyes 3 and 5a–e.
Dye R1 R2 λmax a (nm) log εmax a F b Φ∆ b
3 - - 660 4.85 0.03 0.05
5a H H 661 5.40 0.02 0.22
5b H CH3 670 4.96 0.03 0.26
5c CH2CH2OH CH2CH2OH 679 4.91 0.01 0.09
5d H CH2CH2OH 671 5.04 0.11 0.19
5e CH3 CH2CH2OH 682 4.50 0.09 0.16
a In MeOH/CH2Cl2, 99/1 (v/v); b In CHCl3.
2.2.2. Singlet Oxygen Quantum Yields
The evaluation of the photosensitizing efficiency of the aminosquaraine dyes was performed in
chloroform, by determining the singlet oxygen formation quantum yields (Φ∆). Phenazine was used
as standard [41,42]. The phosphorescence emission of singlet oxygen generated by the sensitizers at
approximately 1270 nm is presented in Figure 2 and the determined quantum yields are summarized
in Table 1.
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These Φ∆ values were obtained by a simple comparison of the integrated areas determined for
the standard and samples, using the same OD at the excitation wavelength. For each determination an
average of 100 phosphorescence spectra were used. Dye 5b displays the highest quantum yield when
compared to the other squaraine derivatives (Φ∆ = 0.26). As previously reported [43,44], the amino
group in the squaric ring enhances singlet oxygen generation efficiency when compared with the
unsubstituted zwitterionic dye 3. The results for Φ∆ are strongly dependent on the nature of the
amino substituents: the highest Φ∆ values occurred for the smallest substituents, and the lowest values
were observed for the hydroxyethylamino substituents, especially the bis(hydroxyethyl)-amino group
(dye 5c). This is related with the intramolecular charge transfer (ICT) mechanism which provides
a non-radiative deactivation pathway, therefore decreasing the singlet oxygen formation quantum
yields ([44] and references therein).
2.2.3. Fluorescence Quantum Yields
Table 1 also presents the fluorescence quantum yields ΦF for the aminosquaraines 5a–e in CHCl3.
As expected, due to the covalent link between iodine and the aminosquaraine, a strong heavy atom
effect can be observed in all cases. This effect is emphasized in the case of the bis(hydroxyethyl)amino
substituent group (dye 5c).
2.3. In Vitro Photodynamic Activity
Four human tumor cell lines were used to assess the in vitro cytotoxicity of the synthesized
dyes (5a–e): cervical (HeLa), breast (MCF7), hepatocellular (HepG2) and non-small cell lung
(NCI-H460) carcinomas.
Although cytotoxicity was found to depend on the cell line, in general, all aminosquaraine dyes
exhibited much higher cytotoxicity upon irradiation than in the absence of light. This fact revealed that
the dyes are endowed with photodynamic action capacity. The assurance that the photodynamic effect
was due, exclusively, to the sensitizing properties of the squaraine dyes, was secured by observing,
in independent assays submitted to the photodynamic treatment and maintained in the dark, that,
in the absence of the dyes neither DMSO nor light individually, nor the combination of both, were able
to induce toxicity on the cells.
Figure 3 shows the growth inhibition ability of aminosquaraines 5a–e against the different human
tumor cell lines, in the absence of light and upon irradiation, at a dye concentration of 0.3 µM. In this
representative example, the growth inhibition in the dark was less than 20% in more than 75% of
the assays.
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Figure 3. Growth inhibition of HeLa, HepG2, MCF-7 and NCI-H460 cell lines upon treatment with
dyes 5a–e (0.3 µM) in the dark and after irradiation. Results correspond to two independent assays
and are presented as mean values ± standard deviation (SD).
Whatever the cell line, dyes 5a and 5b exhibited, invariably, the larger differences between the
growth inhibition percentages upon illumination and in the dark (~ 46–68% and ~ 43–73%, respectively).
In case of dye 5a the more pronounced differences in growth inhibition under the two conditions was
found against the MCF-7 cell line, closely followed by the NCI-H460 cell line, while for ye 5b the
larger difference was observed for the MCF-7 cell line. Dye 5c displayed the weaker photocytotoxic
capability, presenting the smaller differences of growth inhibition in the presence and in the absence of
light, for the HepG2, MCF-7 and NCI-H460 cell lines. For the HeLa cells dye 5d showed to be the less
efficient sensitizer. It is worthwhile to mention that, though determined in CHCl3, dye 5c exhibited the
lowest singlet oxygen generation quantum yield among all dyes tested.
The GI50 values (concentration causing 50% cell growth inhibition) for aminosquaraines 5a-e were
also determined and are presented in Table 2. The differences found between the values determined
for the assays in the dark and upon irradiation, clearly demonstrated once more the photocytotoxic
ability of the dyes.
Table 2. Cytotoxicity (GI50 values, µM) of aminosquaraine dyes 5a–e (mean ± SD).
Dye Condition HeLa HepG2 MCF-7 NCI-H460 PLP2
5a
Dark 2.54 ± 0.02 20 ± 2 15 ± 1 15.3 ± 0.8 17.5 ± 0.1
Irr diated 0.004 ± 0.00 1 0.08 ± .001 0.01 ± 0.001 0.19 ± 0.02 2.0 ± 0.1
t-Student test p-value < .001 <0.001 <0.001 < .001 <0.0 1
5b
Dark 1.2 ± 0.1 15 ± 2 10.0 ± 0.7 8.1 ± 0.9 5.7 ± 0.6
Irr diated 0.01 ± 0.0 0.06 ± 0.001 0.01 ± .001 0.18 ± 0.07 0.03 ± 0.001
t-Student test p-value <0.001 <0.001 <0.001 <0.001 <0.001
5c
Dark 2.0 ± .1 23 ± 2 >25 23 ± 2 22.0 ± 0.9
Irr diated 0.31 ± 0. 3 0.26 ± 0,03 0.42 ± 0.06 0.98 ± 0.04 0.44 ± .01
t-Student test p-value <0.001 <0.001 - <0.001 <0.001
5d
Dark 1.8 ± .1 >25 >25 >25 >25
Irradiated 0.19 ± 0.01 0.38 ± 0.03 0.25 ± 0.04 0.89 ± 0.01 0.98 ± 0.02
t-Student test p-value <0.001 - - - -
5e
Dark 2.1 ± .2 11.4 ± 0.9 9.6 ± 0.2 13 ± 1 11.9 ± 0.2
Irradiated 0.19 ± 0.02 0.19 ± 0.01 0.23 ± 0.02 0.24 ± 0.03 0.42 ± 0.01
t-Student test p-value <0.001 <0.001 <0.001 <0.001 <0.001
Among all compounds, 5a and 5b consistently presented the lowest GI50 values upon illumination
for all the cell lines tested, ranging from 0.004 µM to 0.19 µM. In absence of light the GI50
va es increased ca. 80–1500 tim for 5 and ca. 45–25 times for 5b, depending o the cell line.
With exception of the HeLa cells, dye 5d showed to be inactive in the dark (GI50 > 25 µM) against all
the cells lines within the range of the concentrations us d.
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One of the desirable features of any new sensitizer is the lack of toxicity for non-tumor cells.
For that reason aminosquaraines 5a–e were also tested against a non-tumor porcine liver primary cell
culture (PLP2) established by some of us, both in the absence of light and under irradiation. Dye 5a
presented a GI50 value under illumination considerably superior to those determined for the tumor
cell lines. Dyes 5b–d displayed GI50 values against PLP2 cells, both in the dark and under irradiation,
not appreciably different than those obtained for the tumor cell lines used.
Having recently demonstrated the photocytotoxic properties of several aminosquaraine dyes
derived from benzothiazole [36], we anticipated that the introduction of iodine atoms in the terminal
aromatic nucleus of the dyes could increase singlet oxygen generation through the heavy atom effect
and, ultimately, enhance their photocytotoxicity. In fact, the GI50 values obtained for dyes 5a–e under
irradiation were in general smaller, in some cases substantially, than those determined previously for
their non-halogenated analogues. The GI50 values in the dark, on the other hand, were higher, making
aminosquaraines 5a–e safer for application.
3. Materials and Methods
3.1. Chemistry
3.1.1. General Information
All reagents were obtained commercially and used as received. Solvents were of analytical
grade. Anhydrous solvents were dried [45] and freshly distilled. All reactions were monitored
by TLC using 0.20 mm aluminum-backed silica-gel plates (SIL G UV254, Macherey-Nagel, Düren,
Germany). Melting points were measured in a melting-point apparatus equipped with a binocular
microscope (Rotoquímica, Maia, Portugal) and are uncorrected. IR spectra were recorded on a Unicam
Research Series FT-IR spectrophotometer (Mattson Instruments Inc., Madison, WI, USA); νmax in
cm−1. Vis spectra were performed on a Lambda 25 instrument (Perkin-Elmer, Singapore); λmax in nm.
1H- (400.13 MHz) and 13C-NMR spectra (100.61 MHz) were recorded on an ARX 400 spectrometer
(Brüker, Germany); δ in ppm relative to residual solvent signals, J in Hz. High resolution electrospray
ionization time-of-flight mass spectra (HRMS ESI-TOF) were determined on Apex-Q FT-ICR and
micrOTOF mass spectrometers (Bruker, Germany). 6-Iodo-2-methylbenzothiazole (1) was prepared as
previously described [40].
3.1.2. Synthesis of 3-Ethyl-6-iodo-2-methylbenzothiazolium iodide (2)
A mixture of 6-iodo-2-methylbenzothiazole (1, 6.00 g, 22.00 mmol) and a 3-fold excess of
iodoethane (5.40 mL, 66.00 mmol) in CH3CN (150 mL) was heated under reflux for approximately
9 days. Upon cooling Et2O was added and the resulting precipitate was collected by filtration under
reduced pressure and washed with Et2O. Yield: 68%. Yellowish crystals. M.p. > 265 ◦C (dec.).
3.1.3. Synthesis of 4-[(3-Ethyl-6-iodobenzothiazol-3-ium-2-yl)methylidene]-2-[(3-ethyl-6-iodo-3H-
benzothiazol-2-ylidene)methyl]-3-oxocyclobut-1-en-1-olate (3)
A mixture of benzothiazolium salt 2 (2.00 g, 4.64 mmol) and squaric acid (0.27 g, 2.32 mmol) in
n-BuOH/pyridine [9/1 (v/v)] (230 mL) was heated under reflux for about 4 h. The reaction mixture
was then cooled in an ice bath, the resulting precipitate was collected by filtration under reduced
pressure and washed thoroughly with water and Et2O to afford chromatographically pure green
crystals. Yield: 93%. M.p. > 300 ◦C. UV/Vis [MeOH/CH2Cl2, 99/1 (v/v)] λmax (log ε): 660 (4.85);
1H-NMR (DMSO-d6) δ: 8.22 (2H, s, ArH), 7.72 (2H, d, J = 8.0, ArH), 7.32 (2H, d, J = 8.0, ArH), 5.78
(2H, s, CH=C), 4.25 (4H, d, J = 6.8, NCH2CH3), 1.35–1.30 (6H, m, NCH2CH3). HRMS (ESI-TOF) m/z:
683.88936 ([M − I]+, calc. for C24H20I2N3O2S2: 683.88761).
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3.1.4. Synthesis of 3-Ethyl-2-[3-(3-ethyl-6-iodo-3H-benzothiazol-2-ylidenemethyl)-2-methoxy-4-oxo-
cyclobut-2-enylidenemethyl]-6-iodobenzothiazol-3-ium trifluoromethanesulfonate (4)
To a solution of squaraine dye 3 (0.75 g, 1.10 mmol) in anhydrous CH2Cl2 (250 mL), stirred under
N2 atmosphere at r.t., was added an excess of CF3SO3CH3 (1.0 mL, 8.80 mmol). After 22 h the reaction
mixture was quenched with 5% (m/v) aqueous NaHCO3 and the organic layer, after being separated
by decantation, was dried over anhydrous Na2SO4. The solvent was then removed under reduced
pressure to afford green crystals, which were found by TLC to have sufficient purity to be used in the
next step without further purification. Yield: 89.6%. M.p. > 300 ◦C; UV/Vis [MeOH/CH2Cl2, 99/1
(v/v)] λmax (log ε): 644 (5.34).
3.1.5. Synthesis of 2-[2-Amino-3-(3-ethyl-6-iodo-3H-benzothiazol-2-ylidenemethyl)-4-oxocyclobut-2-
enylidenemethyl]-3-ethyl-6-iodobenzothiazol-3-ium iodide (5a)
To a solution of O-methylsquaraine 4 (0.30 g, 0.35 mmol) in anhydrous CH2Cl2 (125 mL),
vigorously stirred under N2 atmosphere at r.t., was added stepwise a 15.5-fold excess of a solution of
2 M NH3 in MeOH. The reaction mixture was stirred at r.t. for 7 days. The resulting precipitate was
collected by filtration under reduced pressure, washed with water and Et2O and dissolved in MeOH.
To this solution was added an approximately equal volume of 14% (m/v) aqueous KI. After stirring at
r.t. for 1h, the precipitated dye was collected by filtration under reduced pressure and washed with
water and Et2O. Yield: 84%. Purple crystals. M.p. > 300 ◦C. UV/Vis [MeOH/CH2Cl2, 99/1 (v/v)]
λmax (log ε): 661 (5.40). 1H-NMR (DMSO-d6) δ: 8.53 (2H, s, NH2), 8.34 (2H, s, ArH), 7.82 (2H, d, J = 8.0,
ArH), 7.46 (2H, d, J = 8.6, ArH), 6.16 (2H, s, CH=C), 4.27 (4H, br q, J = 6.8, NCH2CH3), 1.35 (6H, br t,
J = 6.6, NCH2CH3). 13C-NMR (DMSO-d6) δ: 173.5, 165.7, 159.8, 157.5, 140.0, 136.0, 130.5, 129.7, 114.5,
88.0, 86.1, 41.3, 12.0. HRMS (ESI-TOF) m/z: 683.91317 ([M − I]+, calc. for C24H20I2N3OS2: 683.91168).
3.1.6. Synthesis of 3-Ethyl-2-[3-(3-ethyl-6-iodo-3H-benzothiazol-2-ylidenemethyl)-2-(methylamino)-
4-oxocyclobut-2-enylidenemethyl]-6-iodobenzothiazol-3-ium iodide (5b)
A mixture of O-methylsquaraine 4 (0.10 g, 0.12 mmol) and an excess of 2 M methylamine in
MeOH (0.047 mL, 1.20 mmol), in anhydrous CH2Cl2 (125 mL), was stirred at r.t. under N2 for about
2 days. The reaction mixture was then worked-up as above for 5a. Yield: 70%. Purple crystals. M.p. >
300 ◦C. UV/Vis [MeOH/CH2Cl2, 99/1 (v/v)] λmax (log ε): 671 (4.92). 1H-NMR (DMSO-d6) δ: 8.76 (1H,
s, NHCH3), 8.41 (1H, s, ArH), 8.35 (1H, s, ArH), 7.85–7.80 (2H, m, ArH), 7.52 (1H, d, J = 8.6, ArH), 7.46
(1H, d, J = 8.6, ArH), 6.17 (1H, s, CH=C), 6.05 (1H, s, CH=C), 4.38 (2H, br q, J = 7.3, NCH2CH3), 4.28
(2H, br q, J = 7.0, NCH2CH3), ~3.30 (NHCH3, overlapped with residual HOD signal), 1.32–1.26 (6H,
m, NCH2CH3). 13C-NMR (DMSO-d6): 173.2, 164.1, 160.4, 159.0, 157.0, 156.4, 140.1, 140.0, 136.3, 136.0,
130.8, 130.5, 130.1, 130.0, 114.9, 114.6, 88.9, 88.3, 86.8, 86.2, 41.7, 41.1, 30.4, 12.3, 12.2. HRMS (ESI-TOF)
m/z: 697.92882 ([M − I]+, calc. for C25H22I2N3OS2: 697.92727).
3.1.7. Synthesis of 3-Ethyl-2-{3-(3-ethyl-6-iodo-3H-benzothiazol-2-ylidenemethyl)-2-[bis(2-hydroxy-
ethyl)amino]-4-oxocyclobut-2-enylidenemethyl}-6-iodobenzothiazol-3-ium iodide (5c)
To a solution of O-methylsquaraine 4 (0.30 g, 0.35 mmol) in anhydrous CH2Cl2 (125 mL), under
N2 atmosphere, was added excess diethanolamine (0.084 mL, 0.89 mmol). After being stirred at r.t.
for 9 days the reaction mixture was worked-up as above for 5a and the resulting solid recrystallized
from MeOH. Yield: 74%. Purple crystals. M.p. > 300 ◦C. UV/Vis [MeOH/CH2Cl2, 99/1 (v/v)] λmax
(log ε): 679 (4.91). 1H-NMR (DMSO-d6): 8.39 (2H, s, ArH), 7.83 (2H, d, J = 8.4, ArH), 7.50 (2H, d,
J = 8.6, ArH), 6.09 (2H, s, CH=C), 5.17 (2H, s, NCH2CH2OH), 4.37 (4H, br s, NCH2CH3), 3.78 (8H,
br s, NCH2CH2OH), 1.28 (6H, br s, NCH2CH3). 13C-NMR (DMSO-d6): 173.5, 164.0, 159.2, 156.0, 140.0,
136.19, 130.6, 130.2, 114.8, 88.6, 87.9, 59.2, 53.7, 41.4 12.1. HRMS (ESI-TOF) m/z: 771.96560 ([M − I]+,
calc. for C28H28I2N3O3S2: 771.96288).
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3.1.8. Synthesis of 3-Ethyl-2-{3-(3-ethyl-6-iodo-3H-benzothiazol-2-ylidenemethyl)-2-[(2-hydroxy-
ethyl)amino]-4-oxocyclobut-2-enylidenemethyl}-6-iodobenzothiazol-3-ium iodide (5d)
To a solution of O-methylsquaraine 4 (0.11 g, 0.13 mmol) in anhydrous CH2Cl2 (125 mL) and
CH3CN (60 mL), under N2 atmosphere, was added excess ethanolamine (0.38 mL, 0.63 mmol).
The reaction mixture was stirred at r.t. for about 5 days. The reaction mixture was worked-up
as above for 5a. Yield: 52%. Purplish blue crystals. M.p. > 300 ◦C. UV/Vis [MeOH/CH2Cl2, 99/1
(v/v)] λmax (log ε): 670 (4.96). 1H-NMR (DMSO-d6): 8.90 (1H, s, NHCH2CH2OH), 8.39 (1H, s, ArH),
8.33 (1H, s, ArH) 7.84–7.78 (2H, m, ArH), 7.52–7.43 (2H, m, ArH), 6.29 (1H, s, CH=C), 5.95 (1H, s,
CH=C), 5.13 (1H, s, NHCH2CH2OH), 4.35–4.28 (4H, m, NHCH2CH3), 3.74 (4H, br s, NHCH2CH2OH),
1.34–1.25 (6H, m, NCH2CH3). 13C-NMR (DMSO-d6): 173.6, 163.9, 160.4, 158.9, 157.3, 156.0, 140.1,
140.0, 136.3, 136.1, 130.8, 130.5, 130.1, 114.9, 114.6, 88.9, 88.2, 87.2, 86.5, 60.5, 46.5, 41.7, 41.1, 12.4, 12.0.
HRMS (ESI-TOF) m/z: 727.93938 ([M − I]+, calc. for C26H24I2N3O2S2: 727.93762).
3.1.9. Synthesis of 3-Ethyl-2-{3-(3-ethyl-6-iodo-3H-benzothiazol-2-ylidenemethyl)-2-[(2-hydroxy-
ethyl)methylamino]-4-oxocyclobut-2-enylidenemethyl}-6-iodobenzothiazol-3-ium iodide (5e)
A mixture of O-methylsquaraine 4 (0.99 g, 0.12 mmol) and N-methylethanolamine (0.14 mL,
1.78 mmol) in anhydrous CH2Cl2 (125 mL) and CH3CN (45 mL) was stirred at r.t., under N2 atmosphere,
for approximately 5 days. The precipitated solid was collected by filtration under reduced pressure
and washed with water and Et2O. The mother liquor was washed with water and the organic layer,
after being separated by decantation, was dried over anhydrous Na2SO4 and evaporated to dryness
under reduced pressure. The combined solids underwent counter ion exchange as described for 5a.
Yield: 56%. Blue crystals. M.p. > 300 ◦C. UV/Vis [MeOH/CH2Cl2, 99/1 (v/v)] λmax (log ε): 682 (4.43).
1H-NMR (DMSO-d6): 8.39 (2H, s, ArH), 7.83 (2H, d, J = 8.6, ArH), 7.50 (2H, d, J = 8.8, ArH), 6.10 (2H, s,
CH=C), 5.16 (1H, s, NCH3CH2CH2OH), 4.39 (4H, s, NCH2CH3), 3.74 (4H, s, NCH3CH2CH2OH), 3.48
(3H, s, NCH3CH2CH2OH), 1.28 (6H, t, J = 5.5, NCH2CH3). HRMS (ESI-TOF) m/z: 741.95503 ([M − I]+,
calc. for C27H26I2N3O2S2: 741.95297).
3.2. Photochemistry
Singlet Oxygen Quantum Yield Determinations
The singlet oxygen measurement set-up was assembled in our laboratory as previously
described [43]. As an excitation source we used a nitrogen laser, excitation wavelength = 337 nm.
The detector was an InGaAs CCD (model i-Dus from Andor Technology Limited, Belfast, UK) working
at low temperature (−60 ◦C) coupled to a fixed spectrograph, model Shamrock 163i, also from
Andor. Phenazine (standard) was used at O.D. = 0.6 in chloroform. The Φ∆ values were obtained by
comparing the total area of the emission spectra for the reference and for each dye under study in the
same solvent, with the same optical density at the excitation wavelength. Phenazine (standard) was
used at OD = 0.60 in CHCl3.
3.3. Biology
3.3.1. General
Fetal bovine serum (FBS), L-glutamine, Hank’s balanced salt solution (HBSS), trypsin-EDTA
(ethylenediaminetetraacetic acid), penincillin/streptomycin solution (100 U/mL and 100 mg/mL,
respectively), and RPMI-1640 were from Hyclone (Logan, UT, USA). Acetic acid, ellipticine,
sulforhodamine B (SRB), trypan blue, trichloroacetic acid (TCA) and Tris were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). Water was treated in a Milli-Q water purification system (TGI
Pure Water Systems, Greenville, SC, USA).
Molecules 2019, 24, 863 10 of 14
3.3.2. Preparation of the Solutions of Aminosquaraine Dyes
Stock solutions of the aminosquaraines 5a–e with different concentrations (0.0375 µM, 0.15 µM,
0.6 µM, 6 µM, 12 µM, 25 µM, 50 µM, 500 µM) were prepared using a solution of 3% DMSO in DMEM
and kept at−20 ◦C. Prior to the in vitro assays diluted solutions were prepared with the same solvent to
obtain solutions with final concentrations of 0.03 µM, 0.3 µM, 0.6 µM, 1.25 µM, 2.5 µM and 25 µM. For the
HeLa MCF-7 cell lines solutions with final concentrations of 0.0075 µM and 0.001875 µM were additionally
prepared once the inhibition percentage for the 0.03 µM solution was already superior to 50%.
3.3.3. Photodynamic Treatment
The cytotoxicity of the squaraine dyes was tested in the dark and under irradiation. For irradiation
of the cells a halogen/tungsten lamp (24 V and 250 W, Osram, Carnaxide, Portugal) was used
with a fluence rate of 23–24 µW/cm2 (measured with an ILT 1400-A radiometer equipped with
a SEL033 detector, ILT, Peabody, MA, USA). The cells were irradiated continuously for 30 min. A 3%
aqueous solution of K2Cr2O7 was placed between the lamp and the cells as a liquid cut off filter to
remove light of wavelength shorter than ~500 nm. The temperature to which the cells were exposed
was carefully monitored to guarantee cell viability.
3.3.4. Evaluation of Cytotoxicity in Human Tumor Cell Lines
Four human tumor cell lines were used: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small
cell lung carcinoma), HeLa (cervical carcinoma) and HepG2 (hepatocellular carcinoma) from
DSMZ (Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH,
Mönchengladbach, Germany). Cells were routinely maintained as adherent cell cultures in
RPMI-1640 medium containing 10% heat-inactivated FBS and 2 mM glutamine at 3 ◦C, in a
humidified air incubator containing 5% CO2. Each cell line was plated at an appropriate density
(7.5 × 103 cells/well for MCF-7 and NCI-H460, and 1.0 × 104 cells/well for HeLa and HepG2) in
96-well plates, allowed to attach for 24 h and then treated with different concentrations of each
squaraine dye. Controls were set with the cells in the absence of the dyes in 3% DMSO in DMEM
and in the growth medium only. After the incubation step (24 h), the cells were submitted to the
photodynamic treatment for 30 min. Controls in the absence of light were performed on every test.
Neither DMSO alone, nor light alone, nor the combination of both induced toxicity on the cells.
Then, the growth medium was changed and the cells were incubated for further 24 h. Following this
incubation period, the adherent cells were fixed by adding cold 10% TCA (100 µL) and incubated for
60 min at 4 ◦C. Plates were then washed with deionized water and subsequently dried. SRB solution
(0.1% in 1% acetic acid, 100 µL) was then added to each plate well and incubated for 30 min at room
temperature. Unbound SRB was removed by washing with 1% acetic acid. Plates were air dried,
the bound SRB was solubilized with 10 mM Tris (200 µL) and the absorbance was measured at 540 nm
in an ELX800 Microplate Reader (Bio-Tek Instruments Inc., Winooski, VT, USA) [46]. The results were
expressed in GI50 values, which correspond to the concentration of dye that causes 50% inhibition of
cell growth. All the assays were performed in duplicate. Ellipticine was used as standard.
3.3.5. Evaluation of Cytotoxicity in a Porcine Liver Primary Cell Culture
A cell culture was prepared from a freshly harvested porcine liver obtained from a local slaughter
house, and it was designed as PLP2. Briefly, the liver tissues were rinsed in Hank’s balanced salt
solution containing 100 U/mL penicillin and 100 µg/mL streptomycin and divided into 1×1 mm3
explants to ensure that all liver cells were able to access the nutrients provided by the medium. Some of
these explants were placed in 25 cm2 tissue flasks in DMEM medium supplemented with 10% fetal
bovine serum, 2 mM non-essential amino acids and 100 U/mL penicillin, 100 mg/mL streptomycin
and incubated at 37 ◦C with a humidified atmosphere containing 5% CO2. The medium was changed
every two days. Cultivation of the cells was continued with direct monitoring every two or three
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days using a phase contrast microscope. Before confluence was reached, cells were subcultured and
plated in 96-well plates at a density of 1.0 × 104 cells/well, and cultivated in DMEM medium with 10%
FBS, 100 U/mL penicillin and 100 µg/mL streptomycin [47]. The PLP2 cells were incubated with the
squaraine dyes and submitted to the two independent processes—dark and irradiation—as described
earlier for the human tumor cell lines. The SRB assay was performed according to the procedure
previously described. The results were expressed in GI50 values. All the assays were performed in
duplicate. Ellipticine was used as standard.
3.3.6. Statistical Analysis
All the assays were carried out in duplicate. The results are expressed as mean values and
standard deviation. The results were analysed using a Student´s t-test to determine the significant
difference among the different samples, with α = 0.05. This treatment was carried out using SPSS v.
22.0 program (IBM Corp., Armonk, NY, USA).
4. Conclusions
In conclusion, the synthesized aminosquaraine dyes, with strong absorption within the
phototherapeutic window, showed photodynamic activity against the human tumor cell lines studied
(MCF-7, NCI-H460, HeLa, and HepG2), inhibiting cell growth upon irradiation more than in the
absence of light, in some cases substantially. When compared to the non-halogenated analogues
dyes 5a–e exhibited, in general, lower GI50 values under irradiation, which is probably related to the
enhancement of singlet oxygen production through the so-called heavy atom effect. The difference of
cytotoxicity observed in the dark and upon irradiation, turns some of the dyes potential candidates
as photosensitizers for PDT, in particular compound 5a, which showed the lowest toxicity for the
non-tumor primary PLP2 cells.
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